ACELRX PHARMACEUT. DL-01 Financial Flexibility Index
ACELRX PHARMACEUT. DL-01 financial flexibility index. ACELRX PHARMACEUT. DL-01 (R5XA) has a Financial Flexibility Index of -0.19x as of December 2025. Free cash flow of €-2.44 Million (operating CF €-2.44 Million minus capex €0.00) represents 0% of total liabilities (€12.68 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ACELRX PHARMACEUT. DL-01 (2021–2025)
Financial flexibility index of ACELRX PHARMACEUT. DL-01 from 2021 to 2025. Historical Financial Flexibility Index trend for ACELRX PHARMACEUT. DL-01 across 5 annual periods. Check R5XA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
ACELRX PHARMACEUT. DL-01 Financial Flexibility Index by Year (2021–2025)
ACELRX PHARMACEUT. DL-01 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for ACELRX PHARMACEUT. DL-01. For the full cash flow conversion analysis, see R5XA operating cash flow.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.90x | €-11.36 Million | €-11.36 Million | €12.68 Million | ▲ +27.7% |
| 2024 | -1.24x | €-12.68 Million | €-12.68 Million | €10.23 Million | ▲ +55.2% |
| 2023 | -2.77x | €-17.39 Million | €-17.49 Million | €6.29 Million | ▼ -153.8% |
| 2022 | -1.09x | €-27.97 Million | €-28.33 Million | €25.67 Million | ▼ -339.9% |
| 2021 | -0.25x | €-28.18 Million | €-30.00 Million | €113.79 Million | — |